title: [Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia].
abstract: Allogeneic stem cell transplantation (SCT) is an increasingly important therapeutic option for the treatment of adult patients with acute myeloid leukemia. Here we review the current indications of SCT in this disease. While patients with favorable cytogenetics should receive consolidation chemotherapy, patients with unfavorable karyotype are prime candidates for SCT or new approaches to SCT (which should be done in first complete remission). Patients with intermediate prognoses should also receive SCT in first complete remission. In the absence of a suitable matched related donor, most patients will be able to find an alternative donor to proceed to a potentially curative allogeneic transplantation. The use of reduced-intensity conditioning regimens before SCT has allowed patients in the sixth or seventh decades of life to be routinely transplanted. Despite major differences among transplant centers in the intensity and composition of the conditioning regimen and immunosuppression, choice of graft source, postgraft immune-modulation, and supportive care, there has been a dramatic improvement in terms of tolerance. Although it is presumed to be a curative strategy, major complications of SCT remain graft-versus-host disease, delayed immune recovery, multiple comorbidities, and relapse after transplant.
authors.affiliation: Hospices Civils de Lyon, Hôpital Lyon-Sud, service d'hématologie clinique, Pavillon Marcel Bérard, Bât. 1 G, 165 chemin du Grand Revoyet, 69495 Pierre Bénite cedex, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Thomas
mesh_terms: D000328:Adult; D060830:Consolidation Chemotherapy / Q000379:methods; D005838:Genotype; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006648:Histocompatibility; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000628:therapy*; D010641:Phenotype; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous / Q000379:methods
keywords: acute myeloid leukemia; allogeneic stem cell transplantation; myeloablative conditioning; reduced intensity conditioning